Tom 10, Nr 3 (2017)
Sprawozdanie z konferencji / Sprawozdanie
Opublikowany online: 2017-10-25
Wyświetlenia strony
316
Wyświetlenia/pobrania artykułu
2206
Hemafereza lecznicza w świetle danych przedstawionych w czasie 27. regionalnego Kongresu ISBT w Kopenhadze (17–21 czerwca 2017 r.)
Journal of Transfusion Medicine 2017;10(3):99-106.
Streszczenie
xx
Słowa kluczowe: Hemafereza lecznicza
Referencje
- Fernandes AA, Antunes M, Caiado A, et al. Therapeutic apheresis – a center experience. Vox Sanguinis. 2017; 112(supl.1): 254.
- Kirov Z. Rationalization and optimization of the therapeutic plasma exchange application. Vox Sanguinis. 2017; 112(supl.1): 253.
- Esesumaga A, Borges C, Tomaz J. Paraneoplastic neurological syndrome (PNS): three case reports with therapeutic plasma exchange (TPE). Vox Sanguinis. 2017; 112(supl.1): 252.
- Mottola M, Arcopinto C, Brighel F, et al. Treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIPD) with plasmaexchange: short-term response case report. Vox Sanguinis. 2017; 112(supl.1): 253.
- Hwang N, Kim Z, Ham J, et al. Relapsed neuromyelitis optica spectrum disorder, successfully treated by therapeutic plasma exchange: a case report. Vox Sanguinis. 2017; 112(supl.1): 253.
- Lee H, Shin K, Lee S, et al. Increasing use of therapeutic apheresis as a liversaving modality. Vox Sanguinis. 2017; 112(supl.1): 251.
- Kakkar B, Makroo R, Agrawal S, et al. Role of therapeutic plasma exchange in antibody mediated rejection in live related renal transplantation. Vox Sanguinis. 2017; 112(supl.1): 251.
- Sachan D, Verghese J, Saha S, et al. Role of therapeutic plasma exchange (TPE) in patients with drug induced liver injury. Vox Sanguinis. 2017; 112(supl.1): 252.
- Senanayake W, Abeysinghe P, Sumanasekera RA. case report: the efficacy of therapeutic plasma exchange in the management of a patient with atypical presentation of thrombotic thrombocytopenic purpura. Vox Sanguinis. 2017; 112(supl.1): 254.
- Khetarpal K, Kotwal U. Role of automated therapeutic red cell exchange in the setting of acute methemoglobinemia – our experience. Vox Sanguinis. 2017; 112(supl.1): 254.
- Cannizzo E, Spadola V, Saeli A, et al. Patients with sickle cell disease treated with red blood cells exchange: the experience of Ragusa SIMT. Vox Sanguinis. 2017; 112(supl.1): 255.
- Koranova M, Bohonek M, Hrabanek J, et al. Polyglobulia – venesection and double red cell apheresis treatment. Vox Sanguinis. 2017; 112(supl.1): 255.
- Sardo R, Preto R, Esesumaga A, et al. Erythrocytapheresis and phlebotomy to treat red blood cell (RBC) disorders: review from the cellular therapy and apheresis unit of Coimbra Hospital And University Center (CHUC), 2006 to 2016. Vox Sanguinis. 2017; 112(supl.1): 255.
- Orlando N, Iachininoto M, Valentini C, et al. Evaluation of the apoptotic effects of extracorporeal photopheresis for the treatment of chronic graft-vs-host disease. Vox Sanguinis. 2017; 112(supl.1): 251.
- Grzasko N, Morawska M, Hus M. Optimizing the treatment of patients with multiple myeloma and renal impairment. Clin Lymphoma Myeloma Leuk. 2015; 15(4): 187–198.
- Schwartz J, Padmanabhan A, Aqui N, et al. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher. 2016; 31(3): 149–162.
